drugset
drugset / Trial / NCT00000239

Buprenorphine Pharmacology Related to Addiction Treatment - 21

NCT00000239 ↗

Phase 2 Completed National Institute on Drug Abuse (NIDA) University of Vermont · collab
Treatment

Summary

The purpose of this study is to examine if chronic buprenorphine administration will generate supersensitivity to opiates.

Timeline

Start
—
Primary completion
—
Completion
—

Publications

  • Background Bickel, Amass (1995 Experimental & Clinical Psychopharmacology. 3: 477-489 Amass et al 91996) Journal of Substance Abuse Treatment. 13: 43-49 Madden et al., (1997) Experimental & Clinical Psychopharmacology. 5: 1-7. Bickel, Amass (1995) Experimental & Clinical Psychopharmacology. 3: 477-489. Amass et al., (1996) Journal of Substance Abuse Treatment. 13:43-49. Madden et al., (1997) ) Experimental & Clinical Psychopharmacology. 5:1-7.

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified — —

Indications

substance-related disorder